Evidence map›Paper›PMID 36010038›Full record

ArticleChildren (Basel, Switzerland)2022

Implementation of Surfactant Administration through Laryngeal or Supraglottic Airways (SALSA): A Jordanian NICU's Journey to Improve Surfactant Administration.

Naser Aldain A Abu Leyah, Abeer A Hasan, John N Juneau, Maryam Ali Al Jammal, Ghada A Jaber, Gregory E Wilding, Kari D Roberts, Scott O Guthrie

Open access · goldAbstract read
In one paragraph

Article in Children (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Naser Aldain A Abu LeyahDepartment of Pediatrics, Division of Neonatology, Maternity and Children's Hospital at Al Bashir Hospital, Amman 11151, Jordan.ORCID 0000-0001-6331-2050
Abeer A HasanDepartment of Pediatrics, Division of Neonatology, Maternity and Children's Hospital at Al Bashir Hospital, Amman 11151, Jordan.
John N JuneauDepartment of Pediatrics, Division of Neonatology, University of Louisville, Louisville, KY 40202, USA.
Maryam Ali Al JammalDepartment of Pediatrics, Division of Neonatology, Maternity and Children's Hospital at Al Bashir Hospital, Amman 11151, Jordan.
Ghada A JaberDepartment of Pediatrics, Division of Neonatology, Maternity and Children's Hospital at Al Bashir Hospital, Amman 11151, Jordan.
Gregory E WildingDepartment of Biostatistics, State University of New York, Buffalo, NY 14214, USA.
Kari D RobertsDepartment of Pediatrics, Division of Neonatology, University of Minnesota, Minneapolis, MN 55454, USA.
Scott O GuthrieDepartment of Pediatrics, Division of Neonatology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.ORCID 0000-0001-9703-5266
Jordan Hospital · JOUniversity at Buffalo, State University of New York · USUniversity of Louisville · USUniversity of Minnesota · USVanderbilt University · US

Funding

University of Buffalo Clinical and Translational Science Institute - Supplement SchulyerUL1TR001412 · NCATS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI MURPHY, TIMOTHY F · 2015 to 2024
$33.8M
NCATS NIH HHS UL1 TR001412
6 · The paper itself

Abstract

Administration of liquid surfactant through an endotracheal tube for the treatment of respiratory distress syndrome has been the standard of care for decades. Surfactant administration through laryngeal or supraglottic airways (SALSA) is a simplified procedure for delivery of surfactant that is less invasive and better tolerated. The Al Bashir Maternity and Children’s Hospital NICU in Amman, Jordan, implemented SALSA as a potentially better practice in 2019 with the objective to effectively and efficiently deliver surfactant in a minimally invasive way and to decrease the adverse events associated with intubation−surfactant−extubation (InSurE) and laryngoscopy. The quality improvement initiative was conducted from March 2019 to December 2019. All infants who weighed 750 g or more who required surfactant were eligible. As physicians were trained in the technique and use expanded, we were able to use plan−do−study−act cycles to observe differences between SALSA and InSurE. The primary aim was the optimization of non-invasive ventilation by the effective and efficient delivery of surfactant. Balancing measures included episodes of bradycardia while receiving surfactant or the need for a second dose of surfactant. We evaluated 220 infants who received surfactant by SALSA or InSurE with a mean gestational age of 32 weeks and a mean birth weight of 1.8 kg. The Respiratory Severity Score (RSS) prior to surfactant administration was 2.7 in the SALSA group compared to 2.9 in the InSurE group (p = 0.024). Those in the InSurE group had a lower mean heart rate during the procedure (p =< 0.0001) and were more likely to need a second dose of surfactant (p = 0.026) or require intubation for mechanical ventilation (p = 0.022). Both groups were effectively delivered surfactant as evidenced by improvement in their RSS over an 8 h period. SALSA was a more time efficient surfactant delivery method (93 vs. 111 secs, p =< 0.0001). Implementation of SALSA into the Al Bashir NICU was successful. We found that it was equally effective to InSurE, but was a more efficient method of delivery. Infants who received surfactant by this method tolerated it well.

Indexed as

intubation–surfactant–extubation (InSurE)LMARespiratory Distress Syndrome (RDS)supraglottic airways (SALSA)surfactant

Identifiers

PMID36010038
PMCPMC9406484
OpenAlexW4289109889

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.